colorectal cancer

colorectal cancer
Field	Oncology, Gastroenterology

colorectal cancer. It is a malignant neoplasm arising from the epithelial lining of the colon or rectum, forming a major part of the gastrointestinal tract. The disease typically develops from precancerous growths known as adenomatous polyps over many years. Its management involves a multidisciplinary approach spearheaded by specialists in Oncology and Gastroenterology, with significant global public health initiatives led by organizations like the World Health Organization.

Signs and symptoms

Early stages are often asymptomatic, but as the tumor progresses, common presentations include a persistent change in bowel habits, such as diarrhea or constipation, and rectal bleeding or blood in the stool. Patients may experience abdominal discomfort, cramps, or pain, and a feeling that the bowel does not empty completely. Unexplained weight loss, fatigue, and iron-deficiency anemia are frequent systemic signs. In advanced cases, obstruction can lead to severe pain and vomiting, while metastasis to organs like the Liver or Lungs may cause jaundice or respiratory symptoms. The American Cancer Society emphasizes awareness of these signs for early detection.

Causes and risk factors

The primary cause is the accumulation of genetic mutations in colonic epithelial cells, with both hereditary and environmental factors playing crucial roles. Major hereditary syndromes include Lynch syndrome and Familial adenomatous polyposis, which significantly elevate lifetime risk. Key modifiable risk factors are a diet high in red or processed meats, low physical activity, obesity, smoking tobacco, and heavy alcohol consumption. Chronic inflammatory conditions of the bowel, such as Ulcerative colitis or Crohn's disease, also increase susceptibility. Age is a dominant factor, with most cases diagnosed after age 50, though incidence is rising in younger populations.

Diagnosis

Diagnosis begins with a clinical history and physical examination, including a digital rectal exam. The cornerstone of screening and diagnosis is a colonoscopy, which allows direct visualization of the entire colon and biopsy of suspicious lesions. Other endoscopic procedures include Sigmoidoscopy. Fecal occult blood tests, such as the FIT test, and the multi-target stool DNA test are non-invasive screening tools. Imaging studies like Computed tomography colonography can be used. Blood tests may reveal anemia or elevated levels of the tumor marker Carcinoembryonic antigen. Pathological analysis of biopsy specimens by a Pathologist confirms the diagnosis.

Staging

Staging follows the internationally recognized TNM staging system developed by the American Joint Committee on Cancer and the Union for International Cancer Control. This system classifies the cancer based on the depth of tumor invasion (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). Stage 0 indicates carcinoma in situ, while Stage I tumors are confined to the bowel wall. Stage II cancers invade deeper but without lymph node spread, and Stage III involves regional lymph nodes. Stage IV denotes metastasis to distant organs like the Liver, Lungs, or Peritoneum. Accurate staging is critical for determining prognosis and guiding treatment strategy.

Treatment

Treatment is tailored to the stage and location of the cancer, often involving a combination of modalities. Surgical resection, such as a Colectomy or Proctectomy, is the primary curative treatment for localized disease. For rectal cancer, approaches may include Total mesorectal excision. Chemotherapy regimens, often involving drugs like 5-Fluorouracil, Oxaliplatin, or Irinotecan, are used adjuvantly or for advanced disease. Radiation therapy is frequently employed for rectal cancers, sometimes in a neoadjuvant setting. For metastatic cancer, targeted therapies against pathways like EGFR or VEGF, and Immunotherapy agents like Pembrolizumab for tumors with Microsatellite instability, are key options. Treatment decisions are typically made by a multidisciplinary team at comprehensive cancer centers like the Memorial Sloan Kettering Cancer Center.

Prevention

Primary prevention focuses on modifying lifestyle risk factors, including adopting a diet rich in fruits, vegetables, and whole grains, maintaining a healthy weight, engaging in regular physical activity, avoiding tobacco, and limiting alcohol intake. Secondary prevention through screening is highly effective, as it allows for the detection and removal of precancerous polyps. Guidelines from the U.S. Preventive Services Task Force recommend regular screening via colonoscopy, sigmoidoscopy, or stool-based tests starting at age 45 for average-risk individuals. For those with hereditary syndromes like Lynch syndrome, more intensive surveillance and sometimes prophylactic surgery are considered. Aspirin chemoprevention may be discussed for certain high-risk individuals.

Epidemiology

It is the third most commonly diagnosed cancer and the second leading cause of cancer death worldwide according to GLOBOCAN estimates. Incidence rates are highest in developed regions such as Australia, New Zealand, Europe, and North America, though rates are increasing rapidly in many transitioning countries. Historically, it has been more common in men than women. While incidence and mortality have been declining in older adults in many high-income countries due to effective screening and improved treatment, there is a concerning rise in incidence among adults under 50, a trend noted by researchers and public health agencies like the Centers for Disease Control and Prevention. Disparities in outcomes are often linked to socioeconomic status and access to screening services.

Category:Diseases and disorders